References
- Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614–36
- Zhang R, Chen W, Adams P. Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 2007;27:2343–58
- Herbig U, Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 2006;127:16–24
- Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005;436:725–30
- Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature 2005;436:642
- Narita M, Narita M, Krizhanovsky V, et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006;126:503–14
- Zhang R, Poustovoitov MV, Ye X, et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 2005;8:19–30
- Hassold T, Abruzzo M, Adkins K, et al. Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen 1996;28:167–75
- Hassold T, Chiu D. Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy. Hum Genet 1985;70:11–7
- Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet 2012;13:493–504
- De Souza E, Halliday J, Chan A, et al. Recurrence risks for trisomies 13, 18, and 21. Am J Med Genet A 2009;149A:2716–22
- Morris JK, Mutton DE, Alberman E. Recurrences of free trisomy 21: analysis of data from the National Down Syndrome Cytogenetic Register. Prenat Diagn 2005;25:1120–8
- Warburton D, Dallaire L, Thangavelu M, et al. Trisomy recurrence: a reconsideration based on North American data. Am J Hum Genet 2004;75:376–85
- Epstein CJ, Korenberg JR, Annerén G, et al. Protocols to establish genotype-phenotype correlations in Down syndrome. Am J Hum Genet 1991;49:207–35
- Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down’s syndrome: a review. Pediatr Hematol Oncol 1987;4:211–30
- Maloney KW. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review. Br J Haematol 2011;155:420–5
- Coppus A, Evenhuis H, Verberne GJ, et al. Dementia and mortality in persons with Down’s syndrome. J Intellect Disabil Res 2006;50:768–77
- Zigman WB, Lott IT. Alzheimer’s disease in Down syndrome: neurobiology and risk. Ment Retard Dev Disabil Res Rev 2007;13:237–46
- Patterson D. Molecular genetic analysis of Down syndrome. Hum Genet 2009;126:195–214
- Sukenik-Halevy R, Biron-Shental T, Sharony R, et al. Telomeres in trisomy 21 amniocytes. Cytogenet Genome Res 2011;135:12–18
- Hadi E, Sharony R, Goldberg-Bittman L, et al. Telomere aggregates in trisomy 21 amniocytes. Cancer Genet Cytogenet 2009;195:23–6
- Raynaud CM, Hernandez J, Llorca FP, et al. DNA damage repair and telomere length in normal breast, preneoplastic lesions, and invasive cancer. Am J Clin Oncol 2010;33:341–5
- Salpea KD, Nicaud V, Tiret L, et al. The association of telomere length with paternal history of premature myocardial infarction in the European Atherosclerosis Research Study II. J Mol Med (Berl) 2008;86:815–24
- Valdes AM, Richards JB, Gardner JP, et al. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int 2007;18:1203–10
- Panossian LA, Porter VR, Valenzuela HF, et al. Telomere shortening in T cells correlates with Alzheimer’s disease status. Neurobiol Aging 2003;24:77–84
- von Zglinicki T, Saretzki G, Döcke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995;220:186–93
- Conti A, Fabbrini F, D’Agostino P, et al. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genomics 2007;8:268--283
- Perrin A, Basinko A, Douet-Guilbert N, et al. Aneuploidy and DNA fragmentation in sperm of carriers of a constitutional chromosomal abnormality. Cytogenet Genome Res 2011;133:100–6
- Pathak S, Multani AS. Aneuploidy, stem cells and cancer. EXS 2006;96:49–64
- Hu Y, Lehrach H, Janitz M. Apoptosis screening of human chromosome 21 proteins reveals novel cell death regulators. Mol Biol Rep 2010;37:3381–7